CDC: Olympics May Boost Zika Importation Risk for Four African Countries

People returning from the Olympic and Paralympic Games in Brazil will not substantially affect viral transmission in most participating countries, according to the US Centers for Disease Control and Prevention.

Written byTanya Lewis
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

FLICKR, IAN BURTAs many as half a million people from more than 200 countries are expected to descend on Rio de Janeiro for the Olympic and Paralympic Games in Brazil next month. This represents only a small fraction of total travel to countries with active Zika virus transmission, the US Centers for Disease Control and Prevention (CDC) noted in a report released today (July 13). People returning home from the Olympics may lead to an increased risk of Zika transmission in four African countries, however: Chad, Djibouti, Eritrea, and Yemen.

“Globalization in the 21st century is the primary driver of Zika virus spread that has occurred to date,” report coauthor Martin Cetron, director of the CDC’s Division of Global Migration and Quarantine, told STAT News. “It’s really driven by global aviation and travel and connectivity. And the relative contribution of the Olympics in Rio is quite small compared to that overall risk.”

The CDC estimates that 19 countries that are not currently reporting Zika outbreaks have conditions that could support mosquito-borne transmission of the virus. Of these, return travel from the Olympics represents a risk to only the four aforementioned African countries, because—apart from the Olympics—these nations do not have significant travel to areas where Zika is active, according to the report. The CDC’s findings ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies